Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Senti Biosciences Holdings, Inc. (SNTI)

Senti Biosciences: Director Edward Mathers resigns; CVR record date set for Oct. 30

Neutral Impact 2 of 5 leadership Written later

Edward Mathers resigned from the Senti Biosciences board and all its committees, effective immediately, on October 27, 2026. The Board also set October 30, 2026 as the record date for the previously announced distribution of contingent value rights (CVRs) tied to the merger that closed October 21, 2026.

Key points

  • Edward Mathers resigned from the Board and all committees, effective immediately on October 27, 2026.
  • Board fixed close of business on October 30, 2026 as the record date for the CVR distribution.
  • CVRs relate to the merger agreement dated July 14, 2026, which closed October 21, 2026.

The filing

CompanySenti Biosciences Holdings, Inc. (SNTI)
Form8-K, current report
Filed with the SECOct 27, 2026, 4:38 PM ET
Accession number0001628280-26-067624

Items reported: 5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:45 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.